<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04589793</url>
  </required_header>
  <id_info>
    <org_study_id>TYH2020338</org_study_id>
    <nct_id>NCT04589793</nct_id>
  </id_info>
  <brief_title>COaching Lifestyle Intervention for FErtility</brief_title>
  <acronym>COLIFE</acronym>
  <official_title>COaching Lifestyle Intervention for FErtility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Helsinki</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Eastern Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In Finland, every third woman is overweight (BMI&gt;25) and 11,5% obese (BMI&gt;30). Cohort and&#xD;
      national studies reveal that 46% of fertile-aged men have BMI≥25 and 20% BMI≥30. Overweight&#xD;
      has negative impact on both female and male fertility and weakens markedly the results of&#xD;
      infertility treatments. In this study, 780 infertile couples will be randomized to control&#xD;
      group (conventional infertility treatment) and lifestyle intervention arm undergoing 4&#xD;
      sessions of video-mediated motivational interview, anthropometric measurements, laboratory&#xD;
      tests and epigenetic samples. Economic evaluation of the intervention will also be performed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">September 2025</completion_date>
  <primary_completion_date type="Anticipated">September 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Behavior change</measure>
    <time_frame>6 months</time_frame>
    <description>score from 1 to 4: (smoking + daily vegetable, fruit and berry use &gt;500g + BMI 19-27 + 150 min of moderate exercise/week) No=0, Yes=1 measured at the beginning, at 3 and 6 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>3 years</time_frame>
    <description>Number of live children born</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight change</measure>
    <time_frame>6 months</time_frame>
    <description>weight in kg measured without shoes and with light clothing at the beginning, at 3 and 6 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infertility treatments, number</measure>
    <time_frame>3 years</time_frame>
    <description>Number of infertility treatments needed for a live birth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infertility treatments, mode</measure>
    <time_frame>3 years</time_frame>
    <description>Mode of infertility treatments needed for a live birth (including ovulation induction, insemination, IVF, ICSI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Miscarriage rate</measure>
    <time_frame>3 years</time_frame>
    <description>Number of miscarriages</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height</measure>
    <time_frame>0 months</time_frame>
    <description>Measured without shoes (cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>0 months</time_frame>
    <description>Measured without shoes and with light clothing (kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>3 months</time_frame>
    <description>Measured without shoes and with light clothing (kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>6 months</time_frame>
    <description>Measured without shoes and with light clothing (kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>0 months</time_frame>
    <description>Weight in kilograms divided by the square of height in meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>3 months</time_frame>
    <description>Weight in kilograms divided by the square of height in meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>6 months</time_frame>
    <description>Weight in kilograms divided by the square of height in meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>0 months</time_frame>
    <description>Bioimpedance method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>3 months</time_frame>
    <description>Bioimpedance method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>6 months</time_frame>
    <description>Bioimpedance method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>0 months</time_frame>
    <description>measured at midpoint between the lower margin of the last palpable rib and the top of the iliac crest (cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>3 months</time_frame>
    <description>measured at midpoint between the lower margin of the last palpable rib and the top of the iliac crest (cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>6 months</time_frame>
    <description>measured at midpoint between the lower margin of the last palpable rib and the top of the iliac crest (cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported physical activity</measure>
    <time_frame>0 months</time_frame>
    <description>Minutes per week, International Physical Activity Questionnaire - Short Form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported physical activity</measure>
    <time_frame>6 months</time_frame>
    <description>Minutes per week, International Physical Activity Questionnaire - Short Form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>0 months</time_frame>
    <description>Amount of weekly physical activity, data from Oura ring 3-dimensional accelerometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>3 months</time_frame>
    <description>Amount of weekly physical activity, data from Oura ring 3-dimensional accelerometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>6 months</time_frame>
    <description>Amount of weekly physical activity, data from Oura ring 3-dimensional accelerometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal oxygen uptake</measure>
    <time_frame>0 months</time_frame>
    <description>Functional aerobic capacity prediction model (N-Ex BMI) by Johnson et al 1990</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal oxygen uptake</measure>
    <time_frame>3 months</time_frame>
    <description>Functional aerobic capacity prediction model (N-Ex BMI) by Johnson et al 1990</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal oxygen uptake</measure>
    <time_frame>6 months</time_frame>
    <description>Functional aerobic capacity prediction model (N-Ex BMI) by Johnson et al 1990</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary content</measure>
    <time_frame>0 months</time_frame>
    <description>FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary content</measure>
    <time_frame>6 months</time_frame>
    <description>FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary patterns</measure>
    <time_frame>0 months</time_frame>
    <description>FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary patterns</measure>
    <time_frame>6 months</time_frame>
    <description>FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Folate</measure>
    <time_frame>0 months</time_frame>
    <description>Plasma folate concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Folate</measure>
    <time_frame>6 months</time_frame>
    <description>Plasma folate concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin-D</measure>
    <time_frame>0 months</time_frame>
    <description>Plasma vitamin-D concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin-D</measure>
    <time_frame>6 months</time_frame>
    <description>Plasma vitamin-D concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Zinc</measure>
    <time_frame>0 months</time_frame>
    <description>Plasma zinc concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Zinc</measure>
    <time_frame>6 months</time_frame>
    <description>Plasma zinc concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carbohydrates</measure>
    <time_frame>0 months</time_frame>
    <description>Amount of daily carbohydrates in diet , FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carbohydrates</measure>
    <time_frame>6 months</time_frame>
    <description>Amount of daily carbohydrates in diet, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Protein</measure>
    <time_frame>0 months</time_frame>
    <description>Amount of daily proteins in diet, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Protein</measure>
    <time_frame>6 months</time_frame>
    <description>Amount of daily proteins in diet, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alcohol</measure>
    <time_frame>0 months</time_frame>
    <description>Alcohol consumption per week, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alcohol</measure>
    <time_frame>6 months</time_frame>
    <description>Alcohol consumption per week, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>n-3 fatty acids</measure>
    <time_frame>0 months</time_frame>
    <description>Amount of daily n-3 fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>n-3 fatty acids</measure>
    <time_frame>6 months</time_frame>
    <description>Amount of daily n-3 fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>n-6 fatty acids</measure>
    <time_frame>0 months</time_frame>
    <description>Amount of daily n-6 fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>n-6 fatty acids</measure>
    <time_frame>6 months</time_frame>
    <description>Amount of daily n-6 fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Saturated fatty acids</measure>
    <time_frame>0 months</time_frame>
    <description>Amount of daily saturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Saturated fatty acids</measure>
    <time_frame>6 months</time_frame>
    <description>Amount of daily saturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Monounsaturated fatty acids</measure>
    <time_frame>0 months</time_frame>
    <description>Amount of daily monounsaturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Monounsaturated fatty acids</measure>
    <time_frame>6 months</time_frame>
    <description>Amount of daily monounsaturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polyunsaturated fatty acids</measure>
    <time_frame>0 months</time_frame>
    <description>Amount of daily polyunsaturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polyunsaturated fatty acids</measure>
    <time_frame>6 months</time_frame>
    <description>Amount of daily polyunsaturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep</measure>
    <time_frame>0 months</time_frame>
    <description>Quality of sleep, Basic Nordic Sleep Questionnaire (BNSQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep</measure>
    <time_frame>6 months</time_frame>
    <description>Quality of sleep, Basic Nordic Sleep Questionnaire (BNSQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep, measured</measure>
    <time_frame>0 months</time_frame>
    <description>Quality, sleep disruptions, total sleep duration registered by Oura ring application</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep, measured</measure>
    <time_frame>3 months</time_frame>
    <description>Quality, sleep disruptions, total sleep duration registered by Oura ring application</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep, measured</measure>
    <time_frame>6 months</time_frame>
    <description>Quality, sleep disruptions, total sleep duration registered by Oura ring application</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress recovery</measure>
    <time_frame>0 months</time_frame>
    <description>Night-time heart rate variability regisered by Oura ring application</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress recovery</measure>
    <time_frame>3 months</time_frame>
    <description>Night-time heart rate variability registered by Oura ring application</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress recovery</measure>
    <time_frame>6 months</time_frame>
    <description>Night-time heart rate variability registered by Oura ring application</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression</measure>
    <time_frame>0 months</time_frame>
    <description>Hospital Anxiety and Depression Scale (HADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression</measure>
    <time_frame>3 months</time_frame>
    <description>Hospital Anxiety and Depression Scale (HADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression</measure>
    <time_frame>6 months</time_frame>
    <description>Hospital Anxiety and Depression Scale (HADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fertility quality of life</measure>
    <time_frame>0 months</time_frame>
    <description>FertiQoL International Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fertility quality of life</measure>
    <time_frame>6 months</time_frame>
    <description>FertiQoL International Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>0 months</time_frame>
    <description>Edinburgh Postnatal Depression Scale (EPDS) Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>6 months</time_frame>
    <description>Edinburgh Postnatal Depression Scale (EPDS) Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-determined motivation for physical activity</measure>
    <time_frame>0 months</time_frame>
    <description>Behavioral Regulations for Exercise Questionnaire (BREQ-3, Markland, D. &amp; Tobin, 2004). Includes the subscales: Amotivation, External regulation, Introjected regulation, Identified regulation, Integrated regulation, Intrinsic regulation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-determined motivation for physical activity</measure>
    <time_frame>6 months</time_frame>
    <description>Behavioral Regulations for Exercise Questionnaire (BREQ-3, Markland, D. &amp; Tobin, 2004). Includes the subscales: Amotivation, External regulation, Introjected regulation, Identified regulation, Integrated regulation, Intrinsic regulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intention and action planning for physical activity; Intention to increase physical activity</measure>
    <time_frame>0 months</time_frame>
    <description>Three (adapted) items from the Health Action Process Approach Questionnaire, (Schwarzer R. Modeling health behaviour change: how to predict and modify the adoption and maintenance of health behaviors. Appl Psychol, 2008; 57:1-29)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intention and action planning for physical activity; Intention to increase physical activity</measure>
    <time_frame>6 months</time_frame>
    <description>Three (adapted) items from the Health Action Process Approach Questionnaire (Schwarzer R. Modeling health behaviour change: how to predict and modify the adoption and maintenance of health behaviors. Appl Psychol, 2008; 57:1-29)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-efficacy for physical activity</measure>
    <time_frame>0 months</time_frame>
    <description>18-item scale developed by Albert Bandura (Bandura A. 2006). Guide for constructing self-efficacy scales. In: Pajares F, Urdan T (eds)Self-efficacy beliefs of adolescents. Information Age, Charlotte, pp 307-337)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-efficacy for physical activity</measure>
    <time_frame>6 months</time_frame>
    <description>18-item scale developed by Albert Bandura (Bandura A. 2006). Guide for constructing self-efficacy scales. In: Pajares F, Urdan T (eds)Self-efficacy beliefs of adolescents. Information Age, Charlotte, pp 307-337)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy complications</measure>
    <time_frame>3 years</time_frame>
    <description>Number of pregnancy complications (gestational diabetes, pre-eclampsia, hypertension, fetal growth disorders, preterm birth)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delivery complications</measure>
    <time_frame>3 years</time_frame>
    <description>Number of delivery complications (cesarean section, assisted vaginal delivery, hemorrhage)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal outcome</measure>
    <time_frame>3 years</time_frame>
    <description>Birth weight, cord pH, Apgar score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition of the newborn</measure>
    <time_frame>At birth</time_frame>
    <description>Bioimpedance method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth of the child</measure>
    <time_frame>Up to 16 years of age</time_frame>
    <description>From the records of the national child care centers and schools</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sperm epigenetic profile</measure>
    <time_frame>0 months</time_frame>
    <description>Determination of heritable phenotype</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sperm epigenetic profile</measure>
    <time_frame>6 months</time_frame>
    <description>Determination of heritable phenotype</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transcriptome</measure>
    <time_frame>0 months</time_frame>
    <description>RNA-sequencing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transcriptome</measure>
    <time_frame>6 months</time_frame>
    <description>RNA-sequencing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sperm oxidative stress</measure>
    <time_frame>0 months</time_frame>
    <description>the Male infertility Oxidative System test (MiOXSYS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sperm oxidative stress</measure>
    <time_frame>6 months</time_frame>
    <description>the Male infertility Oxidative System test (MiOXSYS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A cost-utility of the intervention</measure>
    <time_frame>3 years</time_frame>
    <description>analysis based on WHOQOL-BREF Questionnaire and FertiQoL, relating the quality-adjusted life years (QALYS) to the costs of the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QALY baseline</measure>
    <time_frame>0 months</time_frame>
    <description>WHOQOL-BREF Questionnaire and FertiQoL International Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QALY end point</measure>
    <time_frame>6 months</time_frame>
    <description>WHOQOL-BREF Questionnaire and FertiQoL International Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>3 years</time_frame>
    <description>ICER</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Static postural balance</measure>
    <time_frame>0 months</time_frame>
    <description>Absolute reach distance measured on balance board, cm (FTC Functional training Company GmbH, AM Haag 10 D-82166 Gräfelfing Germany)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Static postural balance</measure>
    <time_frame>1st trimester of pregnancy</time_frame>
    <description>Absolute reach distance measured on balance board, cm (FTC Functional training Company GmbH, AM Haag 10 D-82166 Gräfelfing Germany)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Static postural balance</measure>
    <time_frame>2nd trimester of pregnancy</time_frame>
    <description>Absolute reach distance measured on balance board, cm (FTC Functional training Company GmbH, AM Haag 10 D-82166 Gräfelfing Germany)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Static postural balance</measure>
    <time_frame>3rd trimester of pregnancy</time_frame>
    <description>Absolute reach distance measured on balance board, cm (FTC Functional training Company GmbH, AM Haag 10 D-82166 Gräfelfing Germany)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Static postural balance</measure>
    <time_frame>3 months postpartum</time_frame>
    <description>Absolute reach distance measured on balance board, cm (FTC Functional training Company GmbH, AM Haag 10 D-82166 Gräfelfing Germany)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perception of stress</measure>
    <time_frame>0 months</time_frame>
    <description>Perceived Stress Scale by Sheldon Cohen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perception of stress</measure>
    <time_frame>3 months</time_frame>
    <description>Perceived Stress Scale by Sheldon Cohen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perception of stress</measure>
    <time_frame>6 months</time_frame>
    <description>Perceived Stress Scale by Sheldon Cohen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Personality dimensions</measure>
    <time_frame>0 months</time_frame>
    <description>The Big Five Personality Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Personality dimensions</measure>
    <time_frame>6 months</time_frame>
    <description>The Big Five Personality Test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1560</enrollment>
  <condition>Life Style</condition>
  <condition>Fertility Disorders</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Conventional treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Motivational interview</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Life Style</intervention_name>
    <description>Life Style intervention including physical activity, diet, sleep and stress</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  infertility&#xD;
&#xD;
          -  BMI 27-34.9 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  no mobile device available&#xD;
&#xD;
          -  evident sperm defect or ovarian tube block&#xD;
&#xD;
          -  hinder for fluent treatment schedule due to the subjec´s obstacle (inadequate language&#xD;
             skills, major time table problems)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juha Tapanainen, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maritta Poyhonen-Alho, PhD</last_name>
    <phone>+358 50 428 4690</phone>
    <email>maritta.poyhonen-alho@hus.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paivi Joki-Korpela, PhD</last_name>
    <phone>+358</phone>
    <email>paivi.joki-korpela@hus.fi</email>
  </overall_contact_backup>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 9, 2020</study_first_submitted>
  <study_first_submitted_qc>October 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Maritta Poyhonen-Alho</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Infertility</keyword>
  <keyword>Life Style</keyword>
  <keyword>Physical activity</keyword>
  <keyword>Diet</keyword>
  <keyword>Sleep and stress</keyword>
  <keyword>Intervention</keyword>
  <keyword>Obesity</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>According to request and after consideration of the study group</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

